Skip to content

Clinical trials

Recruiting Small Cell Lung Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Recruiting Clear all

216 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20051
20141
20151
20161
20171
20182
20193
20205
20213
202213
202324
202440
202557
202661

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting216

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sichuan Baili Pharmaceutical Co., Ltd.6
Suzhou Zelgen Biopharmaceuticals Co.,Ltd6
Memorial Sloan Kettering Cancer Center5
National Cancer Institute (NCI)5
Shanghai Pulmonary Hospital, Shanghai, China5
Boehringer Ingelheim4
Cancer Institute and Hospital, Chinese Academy of Medical Sciences4
Shanghai Chest Hospital4
Amgen3
Novartis Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma216
Carcinoma, Non-Small-Cell Lung51
Lung Neoplasms35
Ovarian Neoplasms15
Colorectal Neoplasms14
Endometrial Neoplasms13
Triple Negative Breast Neoplasms13
Carcinoma, Renal Cell12
Squamous Cell Carcinoma of Head and Neck12
Uterine Cervical Neoplasms12

Trials

Showing 51 to 75 of 216. Each trial links to its page on Pharma Observatory.

116 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.